In the last few years, three new herpesviruses, HHV-6, -7 and -8, have been discovered, which share interesting biological characteristics for a possible role in the development of both neurological and lymphoproliferative diseases. In particular HHV-8, besides being strongly associated with Kaposi’s sarcoma, is related with several lymphoproliferative diseases. More recently, specific viral sequences belonging to HHV-8 have been detected in autoptic brain specimens from multiple sclerosis patients and controls, suggesting that, similarly to HHV-6, this novel herpesvirus is strongly neurotropic. HHV-8 is an unusual herpesvirus in that it is able to produce homologues of several human gene products, resulting in alterations in cell cycle, in apoptosis and cell-mediated immune responses. To verify a possible relationship between HHV-8 and the development of amyotrophic lateral sclerosis (ALS), we investigated the presence of signs of HHV-8 infection, by both nested polymerase chain reaction (nPCR) and indirect immune fluorescence analysis in ALS patients. Both PCR and serological data did not suggest a clear role of this virus in originating ALS. Nevertheless, new insights into the mechanisms by which viruses may interact with the host cell genome and with the human immune system make the viral hypothesis of ALS still worthy of further studies.

Keywords:
Human herpesvirus 8, Amyotrophic lateral sclerosis, Polymerase chain reaction
1.
Jubelt B: Motor neuron diseases and viruses: Poliovirus, retroviruses, and lymphomas. Curr Opin Neurol Neurosurg 1992;5:655–658.
2.
Rasmussen HB, Perron H, Clausen J: Do endogenous retroviruses have etiological implications in inflammatory and degenerative nervous system diseases? Acta Neurol Scand 1993;88:190–198.
3.
Rowland LP: Amyotrophic lateral sclerosis. Curr Opin Neurol 1994;7:310–315.
4.
Berger MM, Kopp N, Vital C, Reedl B, Aymard M, Lina B: Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 2000:54:20–25.
5.
Engel WK: Does a retrovirus cause amyotrophic lateral sclerosis? Ann Neurol 1991;30:431–433.
6.
Prentice A, Engel WK, Rasheed S: Amyotrophic lateral sclerosis (ALS) associated with HTLV-I infection. Neurology 1992;42(suppl 3):454–455.
7.
Rowland LP, Sherman WH, Latov N, Lange DJ, McDonald TD, Younger DS, Murphy PL, Hays AP, Knowles D: Amyotrophic lateral sclerosis and lymphoma: Bone marrow examination and other diagnostic tests. Neurology 1992;42:1101–1102.
8.
Ivasaki Y: Human T cell leukemia virus type I infection and chronic myelopathy. Brain Pathol 1993;3:1–10.
9.
Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645.
10.
Verma RK, Ziegler DK, Kepes JJ: HIV-related neuromuscular syndrome simulating motor neuron disease. Neurology 1990;40:544–546.
11.
Galassi G, Gentilini M, Ferrari S, Ficarra G, Zonari P, Mongiardo N, Tommelleri G, Di Rienzo B: Motor neuron disease and HIV-1 infection in a 30-year-old HIV-positive heroin abuser: A causal relationship? Clin Neuropathol 1998;17:131–135.
12.
Ferrante P, Westarp ME, Mancuso R, Puricelli S, Westarp MP, Mini M, Caputo D, Zuffolato MR: HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis. J Neurol Sci 1995;129(suppl):140–144.
13.
Westarp ME, Kornhuber HH, Rossler J, Flugel RM: Human spuma retrovirus antibodies in amyotrophic lateral sclerosis. Neurol Psychiatr Brain Res 1992;1:1–4.
14.
Gardner MB: Retroviral leukemia and lower motor neuron disease in wild mice: Natural history, pathogenesis, and genetic resistance. Adv Neurol 1991;56:473–479.
15.
Kay DG, Gravel C, Pothier F, Laperrier A, Robitaille Y, Joliceur P: Neurological diseases induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc Natl Acad Sci USA 1993;90:4538–4542.
16.
Sola P, Merelli E, Marasca R, Poggi M, Luppi M, Montorsi M, Torelli G: Human herpesvirus 6 and multiple sclerosis: Survey of anti HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993;56:917–919.
17.
Luppi M, Barozzi P, Majorana A, Marasca R, Torelli G: Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994;169:943–944.
18.
Merelli E, Bedin R, Sola P, Barozzi P, Mancardi GL, Ficarra G, Franchini G: Human herpesvirus 6 and human herpesvirus 8 DNA sequences in brains of multiple sclerosis patients, normal adults and children. J Neurol 1997;244:450–454.
19.
Luppi M, Marasca R, Barozzi P, Ferrari S, Ceccherini-Nelli L, Merelli E, Torelli G: Three cases of human herpesvirus-6 latent infection: Integration of viral genome in peripheral blood mononuclear cell DNA. J Med Virol 1993;40:44–52.
20.
Torelli G, Barozzi P, Marasca R, Cocconcelli P, Merelli E, Ceccherini-Nelli L, Ferrari S, Luppi M: Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo. J Med Virol 1995;46:178–188.
21.
Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, Dewhurst S, Insel R, Epstein LG: Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994;170:1586–1589.
22.
Merelli E, Sola P, Barozzi P, Torelli G: An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection. J Neurol Sci 1996;137:42–46.
23.
Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tshachler E, Wong-Staal F, Gallo RC: Productive dual infection of human CD4+ T lymphocytes by HIV-I and HHV-6. Nature 1989;337:370–373.
24.
Torelli G, Marasca R, Luppi M, Selleri L, Ferrari S, Narni F, Mariano MT, Federico M, Ceccherini-Nelli L, Bendinelli M, Montagnani G, Montorsi M, Artusi T: Human herpes virus 6 (HHV-6) in human lymphomas: Identification of specific sequences in Hodgkin’s lymphomas by polymerase chain reaction (PCR). Blood 1991;77:2251–2258.
25.
Wilborn F, Schmidt CA, Brinkmann V, Jendrosha K, Oettle H, Siegert W: A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994;49:213–214.
26.
Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer JC: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440–7444.
27.
Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S: Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997;3:1394–1397.
28.
Mackenzie IRA, Carrigan DR, Wiley CA: Chronic myelopathy associated with human herpesvirus-6. Neurology 1995;45:2015–2017.
29.
Sola P, Merelli E, Levani M, Giovannetti R, Barozzi P: Human herpesvirus 6 (HHV-6) in amyotrophic lateral sclerosis: A polymerase chain reaction (PCR) study. Eur J Neurol 1996;3:315–318.
30.
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994;266:1865–1869.
31.
Rady PL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, Tyring SK: Herpesvirus-like DNA sequences in non-Kaposi’s sarcoma skin lesion of transplant patients. Lancet 1995;354:1339–1340.
32.
Luppi M, Barozzi P, Maiorana A, Artusi T, Trovato R, Marasca R, Savarino M, Ceccherini-Nelli L, Torelli G: Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996;87:3903–3909.
33.
Cesarman E, Knowles DM: The role of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV8) in lymphoproliferative diseases. Semin Cancer Biol 1999;9:165–174.
34.
Mikala G, Xie J, Berencsi G, Kiss C, Marton I, Domjan G, Valyi-Nagy-I: Human herpesvirus 8 in hematologic diseases. Pathol Oncol Res 1999;5:73–79.
35.
Said JW, Tasaka T, de-Vos S, Koeffler HP: Kaposi’s sarcoma-associated herpesvirus/human herpesvirus type 8 encephalitis in HIV-positive and -negative individuals. AIDS 1997;11:1119–1122.
36.
World Federation of Neurology: Criteria for diagnosis of amyotrophic lateral sclerosis. World Neurol 1990;5:12.
37.
Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA: Herpes-like sequences in HIV-infected and uninfected Kaposi’s sarcoma patients. Science 1995;268:582–583.
38.
Kondo H, Nagafuji H, Hata C, Tomomori C, Yamanishi K: Association of human herpesvirus 6 of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993;167:1197–1200.
39.
Kwok S, Higuchi SH: Avoiding false positive with PCR. Nature 1989;339:237–239.
40.
Saiki RK, Bugawan TL, Horn GT, Mullis K, Erlich HA: Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986;324:163–166.
41.
Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 1995;346:799–802.
42.
Appel SH, Smith GR, Engelhart JI, Stefani E: Evidence for autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci 1993;118:169–174.
43.
Offen D, Halevi S, Orion D, Mosberg R, Stern-Goldberg H, Melamed E, Atlas D: Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology 1998;51:1100–1103.
44.
Younger DS, Rowland LP, Latov N, Hays AP, Lange DJ, Sherman W, Inghirami G, Pesce MA, Knowles DM, Powers J, Miller JR, Fetell MR, Lovelace RE: Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78–86.
45.
Thatte U, Dahanukar S: Apoptosis: Clinical relevance and pharmacological manipulation. Drugs 1997;54:511–532.
46.
Boshoff C, Weiss RA: Kaposi’s sarcoma-associated herpesvirus. Adv Cancer Res 1998;75:57–86.
47.
Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G: Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1999;90:395–397.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.